Cardiff Oncology, Inc. is an oncology therapeutics company, which engages in the development of drugs that target mitosis for the treatment of various types of cancer. The firm is focused on developing onvansertib, a first-in-class, third-generation Polo-like Kinase 1 (PLK1) inhibitor, in combination with standard-of-care chemotherapy and targeted therapeutics. Its clinical programs include KRAS-Mutated Metastatic Colorectal Cancer (mCRC), Resistant Metastatic Castration-Resistant Prostate Cancer (mCRPC) and relapsed or refractory Acute Myeloid Leukemia (AML). The company was founded by Gabriel M. Cerrone, L. David Tomei, Samuil Umansky, and Hovsep Melkonyan in 1999 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
31
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Cardiff Oncology Inc market cap is $65.85M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Cardiff Oncology Inc 52 week high is $3.31 as of November 18, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Cardiff Oncology Inc 52 week low is $0.7107 as of November 18, 2026.
Cardiff Oncology Inc stock price today is $0.839.
Cardiff Oncology Inc stock price yesterday was $0.8464.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Cardiff Oncology Inc's P/E ratio is -1.57.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Cardiff Oncology Inc P/B ratio is 2.3434.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Cardiff Oncology Inc 50-day moving average is $1.03.